(-)-Nebivolol

CAS : 118457-16-2

Ref. 3D-FN26170

Informations sur le produit

• Nom: (-)-Nebivolol
• Synonymes: (a-S,a'S,2R,2'S)-a,a'-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol][2S-[2R*[R*[R*(S*)]]]]-a,a'-[Iminobi s(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol, (1S,1'S)-2,2'-iminobis{1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol}, (aS,a,2R,2)-a,a[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol], (aS,a’S,2R,2’S)-a,a’-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol], 2H-1-Benzopyran-2-methanol, α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, (αS,α′S,2R,2′S)-, 2H-1-Benzopyran-2-methanol, α,α′-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, [2S-[2R*[R*[R*(S*)]]]]-, Levonebivolol, R-67145, l-Nebivolol
• CAS: 118457-16-2

Description

Nebivolol is a beta-blocker that has vasodilatory properties. It has been shown to be effective in the treatment of patients with hypertension and heart failure, although it is not used as first-line therapy. Nebivolol is metabolized to its active form by esterases, primarily found in the liver, and is excreted unchanged in urine. The main effect of nebidovolol is reducing the workload on the heart by decreasing the force of contraction and increasing blood flow through peripheral vessels. This drug also inhibits adrenergic receptors, which may lead to a decrease in cardiac contractility.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 405.44 g/mol
• Formule: C₂₂H₂₅F₂NO₄
• Degré de pureté: Min. 95%